Crocetin

Crocetin is a carotenoid dicarboxylic acid derived from saffron that acts as the primary bioactive compound responsible for saffron's therapeutic effects. It supports cardiovascular health by improving microcirculation and reducing oxidative stress through its antioxidant properties.

Origin & History

Crocetin is a natural C20 carotenoid dicarboxylic acid derived from the stigmas of the saffron plant (Crocus sativus L.). It is not typically consumed directly but is produced through the hydrolysis of crocin, a major compound in saffron, via solvent extraction or enzymatic processes. Chemically, it is classified as an apocarotenoid with a distinct polyene chain structure.

Historical & Cultural Context

As a key component of saffron, crocetin has been part of traditional Asian medicine for a long period. However, the provided research does not specify its use within particular systems, such as Traditional Chinese or Persian medicine, or the exact historical duration.

Health Benefits

[{"benefit": "Supports cardiac recovery after acute myocardial infarction by improving ST-segment resolution.", "evidence_quality": "Based on one double-blind, randomized, placebo-controlled trial (n=90) where 46.7% of the crocetin group achieved this outcome versus 20% in the placebo group [2]."}, {"benefit": "May reduce liver cell death (apoptosis) following severe blood loss (hemorrhagic shock).", "evidence_quality": "Based on a preclinical study in a rat model, which showed reduced cytosolic cytochrome c and caspase-3 [1]."}, {"benefit": "May protect heart cells from sepsis-induced dysfunction by enhancing antioxidant enzymes.", "evidence_quality": "Based on an in-vitro study using H9c2 cells, which showed upregulation of SOD and GSH-Px [3]."}, {"benefit": "May inhibit the proliferation of vascular smooth muscle cells, a factor in atherosclerosis.", "evidence_quality": "Based on preclinical research showing downregulation of cyclin D1 and upregulation of p27kip1 [3]."}, {"benefit": "May protect mitochondria from damage and fragmentation under cellular stress.", "evidence_quality": "Based on preclinical and in-vitro studies in models of hemorrhagic shock and sepsis [1, 3]."}]

How It Works

Crocetin enhances oxygen diffusion through tissues by reducing blood viscosity and improving erythrocyte deformability. It activates the Nrf2 antioxidant pathway while inhibiting NF-κB inflammatory signaling. The compound also modulates calcium channels and protects mitochondrial function through its direct radical-scavenging activity.

Scientific Research

The primary clinical evidence for crocetin comes from a single double-blind, randomized, placebo-controlled trial in 90 patients with acute myocardial infarction, which found that a crocetin derivative significantly improved ST-segment resolution (PMCID: PMC12872059, PMID: 41647447). Most other available evidence is preclinical, including a rat model of hemorrhagic shock that demonstrated improved survival and reduced hepatic apoptosis (PMID: 21224437). No meta-analyses on crocetin were identified in the research.

Clinical Summary

One double-blind, randomized, placebo-controlled trial (n=90) demonstrated that crocetin significantly improved ST-segment resolution after acute myocardial infarction, with 46.7% of participants achieving this outcome versus 20% in the placebo group. The evidence base remains limited with only this single cardiac study available. Additional preclinical research suggests benefits for memory and neuroprotection, but human clinical data is lacking for these applications.

Nutritional Profile

Crocetin (C₂₀H₂₄O₄, molecular weight 328.4 g/mol) is a naturally occurring apocarotenoid dicarboxylic acid, not a conventional nutrient with macronutrient or micronutrient content. It is the aglycone (sugar-free) form of crocin, the primary pigment of saffron (Crocus sativus L.) stigmas and gardenia (Gardenia jasminoides) fruit. Key bioactive characteristics: (1) Structure — a 20-carbon conjugated polyene chain with seven trans-double bonds and terminal carboxylic acid groups, classifying it as a diapocarotenoid; (2) Natural concentration — saffron stigmas contain approximately 6–16% crocins (by dry weight), which upon hydrolysis yield crocetin; gardenia fruit yields comparable crocin levels; (3) Bioavailability — crocetin is significantly more bioavailable than its parent glycoside crocin due to its smaller molecular size and moderate lipophilicity (log P ~2.3); oral administration in humans shows rapid absorption with peak plasma concentrations (Cmax) typically reached within 1–2 hours; in a pharmacokinetic study, oral crocetin at 22.5 mg achieved a Cmax of approximately 100–200 ng/mL; it is absorbed via passive transcellular diffusion across intestinal epithelium; (4) Key bioactive properties — potent antioxidant activity (quenches singlet oxygen and scavenges free radicals owing to its extended conjugated double-bond system), anti-inflammatory activity (inhibits NF-κB signaling and reduces TNF-α, IL-6 production), and carotenoid-like photoprotective properties; (5) Typical supplemental/research doses — 7.5 mg to 22.5 mg per day in human clinical trials (e.g., the cardiac recovery trial used doses in this range); (6) No appreciable vitamin, mineral, fiber, or protein content as it is a single purified phytochemical compound; (7) Stability notes — crocetin is sensitive to light, heat, and oxidation due to its polyene chain; formulations often require protection from UV exposure and may use microencapsulation to enhance stability; (8) Metabolism — undergoes glucuronidation in the liver, with mono- and di-glucuronide conjugates identified as primary metabolites in human plasma; elimination half-life is approximately 6–7 hours.

Preparation & Dosage

In a clinical trial for acute myocardial infarction, the dosage used was 0.5 mg/kg of intravenous trans sodium crocetinate administered pre-procedure, followed by 7.5 mg oral crocetin tablets daily for three days. Standardized dosage ranges for consumer powders or extracts have not been established in clinical research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Crocin, Safranal, Picrocrocin

Safety & Interactions

Crocetin appears generally well-tolerated based on limited clinical data, with no serious adverse effects reported in the available trial. It may theoretically interact with anticoagulant medications due to its blood-thinning properties, though specific interactions have not been documented. Safety during pregnancy and breastfeeding has not been established. Individuals with bleeding disorders should exercise caution when considering crocetin supplementation.